SCHEMBL23278082

CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccccc1)C(=O)N1CCCC1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 9)

	gene	UniProt	supporting neighbours	confidence
▸	NMUR2	Q9GZQ4	5/20	0.64

▸	NMUR1	Q9HB89	5/20	0.64

▸	F2	P00734	4/20	0.63

▸	NPY1R	P25929	4/20	0.59

▸	NPY2R	P49146	4/20	0.59

▸	NPY4R	P50391	4/20	0.59

▸	NPY5R	Q15761	4/20	0.59

▸	OPRD1	P41143	1/20	0.59

▸	NTSR1	P30989	1/20	0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29389211	1.00	NMUR2 (0.64)	NMUR2NMUR1F2NPY1RNPY2R
SCHEMBL25739	1.00	NMUR2 (0.64)	NMUR2NMUR1F2NPY1RNPY2R
Acetic Acid SCHEMBL2037978	0.99	NMUR2 (0.63)	NMUR2NMUR1F2NPY1RNPY2R
SCHEMBL28366588	0.99	NMUR2 (0.65)	NMUR2NMUR1F2NPY1RNPY2R
SCHEMBL30753221	0.99	NMUR2 (0.61)	NMUR2NMUR1F2NPY1RNPY2R
SCHEMBL23630197	0.98	NMUR2 (0.62)	NMUR2NMUR1F2NPY1RNPY2R
Trifluoroacetic Acid SCHEMBL4139781	0.98	NMUR2 (0.61)	NMUR2NMUR1F2NPY1RNPY2R
Trifluoroacetic Acid SCHEMBL2034151	0.98	NMUR2 (0.61)	NMUR2NMUR1F2NPY1RNPY2R
Trifluoroacetic Acid SCHEMBL29454826	0.98	NMUR2 (0.61)	NMUR2NMUR1F2NPY1RNPY2R
Trifluoroacetic Acid SCHEMBL16029740	0.97	NMUR2 (0.61)	NMUR2NMUR1F2NPY1RNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-10987315-B1	Antithrombotic nanoparticles and methods for treating necrotizing enterocolitis	UNIVERSITY OF SOUTH FLORIDA (US)	2021-04-27	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-10987315-B1	Antithrombotic nanoparticles and methods for treating necrotizing enterocolitis	SERPINC1, SERPINB1, SELP	NMUR2 1278/4885NMUR1 797/4885F2 110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.